Literature DB >> 34456064

The dimensions of white matter injury in preterm neonates.

Mireille Guillot1, Steven P Miller2.   

Abstract

White matter injury (WMI) represents a frequent form of parenchymal brain injury in preterm neonates. Several dimensions of WMI are recognized, with distinct neuropathologic features involving a combination of destructive and maturational anomalies. Hypoxia-ischemia is the main mechanism leading to WMI and adverse white matter development, which result from injury to the oligodendrocyte precursor cells. Inflammation might act as a potentiator for WMI. A combination of hypoxia-ischemia and inflammation is frequent in several neonatal comorbidities such as postnatal infections, NEC and bronchopulmonary dysplasia, all known contributors to WMI. White matter injury is an important predictor of adverse neurodevelopmental outcomes. When WMI is detected on neonatal brain imaging, a detailed characterization of the injury (pattern of injury, severity and location) may enhance the ability to predict outcomes. This clinically-oriented review will provide an overview of the pathophysiology and imaging diagnosis of the multiple dimensions of WMI, will explore the association between postnatal complications and WMI, and will provide guidance on the signification of white matter anomalies for motor and cognitive development.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain Injury; Hypoxia-Ischemia; Magentic Resonance Imaging; Myelin; Neonate; Oligodendrocyte; Preterm; White Matter Injury

Mesh:

Year:  2021        PMID: 34456064     DOI: 10.1016/j.semperi.2021.151469

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  1 in total

1.  Impact of Physical Contact on Preterm Infants' Vital Sign Response to Live Music Therapy.

Authors:  Susann Kobus; Marlis Diezel; Monia Vanessa Dewan; Britta Huening; Anne-Kathrin Dathe; Ursula Felderhoff-Mueser; Nora Bruns
Journal:  Int J Environ Res Public Health       Date:  2022-08-03       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.